ǰÑÔ
ÁܰÍÁö(lymphoma)ÊDZ¬·¢ÓÚÁÜͶºÏ¼°£¨»ò£©ÁÜͶºÏÍâÁܰÍ×éÖ¯µÄ¶ñÐÔÖ×Áö£¬ÊÇÒ»Àà°üÀ¨¶àÖÖ²î±ðÁÙ´²ÌåÏֺͷÖ×ÓÉúÎïÑ§ÌØÕ÷µÄÖ×Áö¡£½üÄêÀ´£¬Ëæ×۬×̲¡¼°¼Ì·¢ÐÔÃâÒßÒÖÖÆ¼²²¡µÄÔö¶à£¬Æä·¢²¡ÂÊÔÚÌìϸ÷¹úÏÔ×ÅÉÏÉý£¬µ«Æä»ù´¡ºÍÁÙ´²Ñо¿Éî¶ÈºÍ¹ã¶ÈÈÔºÜÓÐÏÞ¡£½üÄêÀ´£¬ÈËÃÇÏà¼Ì½¨ÉèÖÖÖÖÁܰÍÁö¶¯ÎïÄ£×Ó£¬´Ó×Ô¾õÐÔ¡¢ÓÕ·¢ÐÔÖ×ÁöÄ£×Óµ½ÆÕ±éÔËÓõÄÒÆÖ²ÐÔÖ×ÁöÄ£×ÓÒÔ¼°ÔËÓ÷Ö×ÓÉúÎïѧÊÖÒÕ½¨ÉèµÄת»ùÒò¶¯ÎïÄ£×ӵȣ¬ÕâЩģ×ÓΪÉîÈëÑо¿ÁܰÍÁö²¡Òò¡¢·¢²¡»úÖÆ¡¢Õï¶ÏºÍÖÎÁƵÈÌṩÁËÓÐÓõÄÑо¿ÊֶΡ£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
×î³£ÓõÄÓÕµ¼¼ÁÊÇN£¼×»ùÑÇÏõ»ùëå(MNU)¡£ÆäÖ°©»úÖÆÓëO6£¼×»ùÄñàÑßÊÐγÉÓйأ¬ÖÂʹDNA¸´ÖÆÀú³ÌÖб¬·¢GyAµãÍ»±ä¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
ͨ¹ý¸¹Ç»×¢Éä¡¢¾²Âö×¢Éä¡¢¿Ú·þ»ò¹àθµÈ¸øÒ©ÒªÁ죬µ¥´Î»ò·Ö´Î¸øÒ©£¬¾ù¿ÉÓÕµ¼¶àƷϵСÊ󱬷¢ÐØÏÙÁܰÍÁö¡£ÏÖÔÚ×î³£ÓõÄÊǸ¹Ç»×¢Éä·¨£ºÒÔ8mlµÄDMSO 92mlµÄ0.01mol/L PBS(pH=7.2)ΪÈܼÁ£¬½«MNUÅä³ÉŨ¶ÈΪ10mg/mlµÄÓÕµ¼Òº£¬¼´Óü´Å䡣ѡÓÃ6~8ÖÜSPF C57BL/6СÊó£¬êòĵ¾ù¿É¡£¸¹Ç»×¢ÉäMNUÓÕµ¼Òº(50mg/kgÌåÖØ£©£¬¹²×¢Éä2´Î£¨»®·ÖÓÚµÚ0¡¢8ÖÜ£©¡£×¢Éä×îÏȺó¼ÌÐø»ù´¡Òûʳ£¬²¢ÊӲ춯ÎïÌåÖØ¡¢Òûʳ¡¢Ã«É«¡¢Ô˶¯¶ÈµÈÒ»Ñùƽ³£ÇéÐÎת±ä¡£
¡¾Ä£×ÓÌØµã¡¿£º
¢ÙMNUÓÕµ¼µÄСÊóÐØÏÙÁܰÍÁöµÄÐγÉÀú³ÌÏÖʵÉÏÊǵ¥¸öTÁܰÍϸ°ûTCR»ùÒòÖØÅźó£¬ÔÚMNUµÄ×÷ÓÃϱ¬·¢¶ñÐÔת»¯£¬²¢µ¥¿Ë¡ÐÔÔöÉú£¬×îÖÕÈ¡´úÐØÏÙÄÚÕý³£Ï¸°û£¬ÊÇÊôÓÚTϸ°ûȪԴµÄÖ×Áö¡£¢Ú¹âѧÏÔ΢¾µÏÂÐØÏÙ½á¹¹ÆÆËð£¬ÒÔÃÖÂþÂþÑܵÄÖеȾÞϸµÄÁܰÍÑùÖ×Áöϸ°û´úÖ®¡£¢Û¿É¸¹ Ç»×¢Éä¡¢¾²Âö×¢Éä¡¢¿Ú·þ»ò¹àθµÈÒªÁìµ¥´Î»ò·Ö´Î¸øÒ©£¬¾ù¿ÉÓÕ·¢²î±ðƷϵµÄ¶¯Îﱬ·¢ÁܰÍÁö£¬µ«·¢²¡ÂÊÓÐËù²î±ð¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
ÒªÁìÇáÓ¯Ò×ÐУ¬³ÉÁöµÄÏà¶ÔÖÜÆÚ¶Ì¼°ÖÂÁöÂʸߣ»»¯Ñ§Ö°©Îï³£ÓÕ·¢¶à²¿Î»Ö×Áö£¬¹Ê²»³£ÓÃÓÚÒ©Îïɸѡ£»´Ó²¡Òòѧ½Ç¶È¿´£¬ËüÓëÈËÌåÖ×Áö½ÏΪ½üËÆ£¬¹Ê´ËÄ£×Ó³£ÓÃÓÚÌØ¶¨µÄÉîÈëÑо¿¡£
²Î¿¼ÎÄÏ×£º
1.ÓÚÀ×£¬ÁõÓÀÕÜ£¬ËïÊÀÁú£¬µÈ£®c-myc»ùÒòÓë·øÉäÓÕ·¢Ð¡ÊóÐØÏÙÁܰÍÁöµÄ¹ØÁªÐÔÆÊÎö£®¼ªÁÖ´óѧѧ±¨£¨Ò½Ñ§°æ£©£¬2009, 35 (6):971-974
2.ÒüÖ¾»ª£¬ÌÚ·É£¬ÌÆÔËÁ«£¬µÈ£®»·æßËØA¶ÔÎȹÌEBVÓÕ·¢ÁܰÍÁöÄ£×ÓµÄ×÷ÓúÍÒâÒ壮ÖйúÃâÒßѧÔÓÖ¾£¬2002, 18(11):760-763
3.ÇñÑǾ꣬ÕÅÃ÷ÖÇ£¬ÀîÁᣮEB²¡¶¾ÓëÁܰÍÁö£®¹ú¼ÊÖ×ÁöѧÔÓÖ¾£¬2011, 38 (5):387-389
4.»Æ¸ñ·¼£¬ÓàÓ¢ºÀ£¬À£®N£¼×»ùÑÇÏõ»ùëåÓÕµ¼Ð¡ÊóÐØÏÙÁܰÍÁöTCR»ùÒòÖØÅÅÆÊÎö£®Öйú½ÏÁ¿Ò½Ñ§ÔÓÖ¾£¬2010,20(9):7-11
5.Xu D,Wang S,Yu WM,et al. A germline gain-of function mutation in Ptpnl 1 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood,2010, 116(18):3611- 3621
6.Chen HJ.Yang BL,Chen YG,et al. A GFP-labeled human colon cancer metastasis model featuring surgical orthotopic implantation. Asian Pac J Cancer Prev, 2012, 13 (9):4263-4266
7.Chiarle R,Gong JZ,Guasparri¢ñ,et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood, 2003, 101 (5):1919-1927
8.Wang S, Yu WM, Zhang W, et al. Noonan syndrome/ leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN 11) enhance cell migration and angiogenesis. J Biol Chem,2009,284(2):913-920
9.Benavides F, Gomez G, Venables-Griffith A, et al.Differential susceptibility to chemically induced thymic lymphomas in SENGARB and SSIN inbred mice. Mol Carcinog,2006,45 (7):543-548
10.da Silva Franchi CA,Bacchi MM,et al. Thymic lymphomas in Wistar rats exposed to N-methyl-N nitrosourea (MNU). Cancer Sci,2003,94(3):240-243